Adient (ADNT) Q3 2024 earnings summary

Executive summary

• Q3 FY24 revenue declined 8% year-over-year to $3.72B, with adjusted EBITDA at $202M and a GAAP net loss of $11M, mainly due to lower volumes, unfavorable FX, and EMEA headwinds.

• Free cash flow for the quarter was $88M, and $75M was returned to shareholders via share repurchases, totaling $225M YTD, reducing outstanding shares by about 8%.

• Americas and Asia performed in line with or above expectations, while EMEA faced significant challenges from lower demand, customer inefficiencies, and restructuring costs.

• The company remains focused on operational excellence, automation, and innovation, especially in China, with a new JV for mechanical massage systems.

• Guidance for FY24 was revised downward due to reduced customer production and market softness.

Financial highlights

• Q3 consolidated sales were $3.7B, down 8% year-over-year, with adjusted EBITDA at $202M (down 20–27%) and adjusted net income of $29M or $0.32 per share.

• Q3 gross margin declined to 5.6% from 7.4–7.5% prior year, and adjusted EBITDA margin was 5.4% (down from 6.8%).

• Q3 net loss was $11M, compared to $73M net income in Q3 FY23; adjusted EPS was $0.32, down from $0.98.

• Free cash flow for the quarter was $88M, and total liquidity at quarter-end was $1.8B, including $890M in cash and $923M in undrawn revolver capacity.

• Net leverage at June 30, 2024, was 1.87x–1.9x, within the target range.

Outlook and guidance

• FY24 sales guidance updated to $14.6B (from $14.8B–$14.9B), with adjusted EBITDA outlook revised to $870M (from $900M–$920M).

• Free cash flow guidance maintained at $250M, and CapEx forecast reduced to $285M (from $310M).

• Guidance reflects lower vehicle production schedules, customer mix softness, and current market conditions.

• Management expects EMEA restructuring to reduce annual operating costs by ~$100M, with most savings realized by fiscal 2027.

• Business performance is expected to trend higher in Q4, offsetting volume and mix headwinds.